Antifungal activities of the Ml, M 2 and M 5 metabolites of micafungin

Japanese Journal of Chemotherapy

Volumn 50, Issue , 2002, Pages 54-57

  Ikeda, Fumiaki ^a   Otomo, Kazumi ^a   Wakai, Yoshimi ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MICAFUNGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; LOW DRUG DOSE; MALE; MEDICAL ASSESSMENT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE; TRICHOSPORON CUTANEUM;

EID: 0036929747     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.50.Supplement1_54     Document Type: Article

References (1)

1. National Committee for Clinical Laboratory Standards : Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M 27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa., 1997